Signet Ring Cell Carcinoma in Colon Polyp Requires Surgical Resection
Signet ring cell carcinoma identified in a colon polyp biopsy is a high-risk histologic feature that mandates surgical resection with lymph node dissection, regardless of other favorable pathologic features, due to significantly elevated rates of lymph node metastasis and poor prognosis. 1
Clinical Significance
Signet ring cell carcinoma represents an aggressive histologic subtype associated with:
- Significantly worse prognosis compared to well or moderately differentiated adenocarcinoma 1
- Higher rates of lymph node metastasis (odds ratio 2.14 in meta-analysis of 21,238 patients) 1
- Increased risk of recurrence even with apparently complete endoscopic resection 1
- More advanced stage at presentation with frequent peritoneal dissemination 2, 3
The Japanese Society for Cancer of the Colon and Rectum (JSCCR) specifically categorizes signet ring cell carcinoma as "advanced histology" requiring surgery as additional treatment 1. Both the US Multi-Society Task Force (USMSTF) and European Society of Gastrointestinal Endoscopy (ESGE) classify this histology as a high-risk criterion that precludes endoscopic management alone 1.
Management Algorithm
Immediate Actions:
- Refer to colorectal surgery for oncologic resection with lymph node dissection
- Multidisciplinary tumor board review with dedicated GI pathology expert to confirm diagnosis 1
- Complete staging workup including CT chest/abdomen/pelvis and CEA level
Surgical Approach:
- Formal oncologic resection of the involved colonic segment with adequate margins
- Regional lymph node dissection is mandatory given high metastatic potential 4
- Surgery should occur within 2-4 weeks of diagnosis 4
Critical Pitfall to Avoid:
Do not attempt endoscopic surveillance alone, even if:
- The polyp was completely resected with negative margins
- Submucosal invasion is superficial (<1000 μm)
- No lymphovascular invasion is identified
- The polyp was removed en-bloc
While these features would typically allow endoscopic management for well-differentiated adenocarcinoma, signet ring cell histology overrides all other favorable prognostic factors 1.
Important Diagnostic Considerations
Pathology Review Requirements:
- Expert GI pathologist review is essential, as signet ring cell carcinoma can be challenging to diagnose 1
- Submucosal lifting agents can mimic mucin and create diagnostic confusion 1
- Consider metastatic disease from other primary sites (gastric, breast, endometrial) in rare cases 5, 6
Molecular Testing:
Order comprehensive molecular profiling (KRAS, NRAS, BRAF, microsatellite instability status) as signet ring cell carcinomas may harbor actionable mutations that inform adjuvant therapy decisions 4, 2.
Prognosis
Signet ring cell carcinoma of the colon carries significantly worse outcomes than conventional adenocarcinoma:
- Median survival: 17 months vs. 59 months for adenocarcinoma 3
- 5-year survival: 5.9% vs. 46.9% for adenocarcinoma 3
- More common in younger patients and right-sided lesions 3
Comprehensive treatment including surgery, chemotherapy, and consideration of radiotherapy (for rectal lesions) remains the standard approach 3. The aggressive biology of this tumor necessitates oncologic surgical resection even when discovered incidentally in what appears to be a benign polyp 4, 7.